Targeting disease in the developing world Subscription
A new report by the Access to Medicine Index finds that pharmaceutical companies influence access to medicines in developing countries through the development of innovative and adapted products, operating equitable pricing strategies and building local capacity.
Numerous factors influence demand for pharmacists, with a rise in the number of prescriptions and more complex drug regimens increasing demand, and developments in the technician workforce and automation mitigating it in some regions.
A visual guide to the Ebola virus epidemic Subscription
As the 2014 Ebola virus epidemic continues to escalate, we chart the latest epidemiological data alongside an insight into the pathology of Ebola virus disease and the biological processes being targeted by drug and vaccine developers.
A history of aspirin Subscription
Aspirin was one of the first drugs to come into common usage and it still one of the most researched drugs in the world, with an estimated 700 to 1,000 clinical trials conducted each year.
OTC medicines: a breakdown Subscription
Sales of over-the-counter medicines totalled £2.45bn in 2013, up by £52.3m compared with the previous year.